Skip to main content

Dennis H. Giesing

Equibles does not estimate personal net worth.

About Dennis H. Giesing

Immunome Inc. reported in an 8-K filed October 4, 2023 that Dennis H. Giesing was terminated as Immunome's former Chief Development Officer, effective October 2, 2023. The proxy statement of Immunome Inc. reports total compensation of $3,499,917 for Dennis H. Giesing in fiscal 2021, including a base salary of $306,971.

“(iii) Dennis Giesing, Ph.D., Immunome's former Chief Development Officer, was terminated as an officer and employee of Immunome effective as of the closing of the Merger.”
Immunome Inc. Form 8-K, filed October 4, 2023 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Immunome Inc. (IMNM) $306,971 $3,499,917

Recent activity